{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:53:54Z","timestamp":1790679234301,"version":"4.1.0"},"reference-count":139,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2014.00127","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T10:14:45Z","timestamp":1406715285000},"source":"Crossref","is-referenced-by-count":91,"title":["Podocyte Pathology and Nephropathy \u00e2\u20ac\u201c Sphingolipids in Glomerular Diseases"],"prefix":"10.3389","volume":"5","author":[{"given":"Sandra","family":"Merscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Fornoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1042\/bst0030579","article-title":"The second thudichum lecture. Cerebral isolates and neurochemical discovery","volume":"3","author":"McIlwain","year":"1975","journal-title":"Biochem Soc Trans"},{"key":"B2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00020.2002","article-title":"Cell biology of the glomerular podocyte","volume":"83","author":"Pavenstadt","year":"2003","journal-title":"Physiol Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/71724","article-title":"Getting a foothold in nephrotic syndrome","volume":"24","author":"Somlo","year":"2000","journal-title":"Nat Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.tcb.2007.06.006","article-title":"Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton","volume":"17","author":"Faul","year":"2007","journal-title":"Trends Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1097-2765(00)80057-X","article-title":"Positionally cloned gene for a novel glomerular protein \u00e2\u20ac\u201c nephrin \u00e2\u20ac\u201c is mutated in congenital nephrotic syndrome","volume":"1","author":"Kestil\u00c3\u00a4","year":"1998","journal-title":"Mol Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/74166","article-title":"NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome","volume":"24","author":"Boute","year":"2000","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"crossref","first-page":"F785","DOI":"10.1152\/ajprenal.2000.279.4.F785","article-title":"CD2AP is expressed with nephrin in developing podocytes and is found widely in mature kidney and elsewhere","volume":"279","author":"Li","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1106215","article-title":"A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis","volume":"308","author":"Winn","year":"2005","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/73456","article-title":"Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis","volume":"24","author":"Kaplan","year":"2000","journal-title":"Nat Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bbamem.2008.09.002","article-title":"Effects of ceramide and other simple sphingolipids on membrane lateral structure","volume":"1788","author":"Goni","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/BJ20021528","article-title":"Ceramide: second messenger or modulator of membrane structure and dynamics?","volume":"369","author":"van Blitterswijk","year":"2003","journal-title":"Biochem J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbamem.2008.07.030","article-title":"Ceramide-enriched membrane domains \u00e2\u20ac\u201c structure and function","volume":"1788","author":"Zhang","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"B13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/365557a0","article-title":"Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens","volume":"365","author":"Olivera","year":"1993","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1210\/endo.137.11.8895358","article-title":"Tumor necrosis factor-alpha and its second messenger, ceramide, stimulate apoptosis in cultured ovarian follicles","volume":"137","author":"Kaipia","year":"1996","journal-title":"Endocrinology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1753-4887.1992.tb01273.x","article-title":"Ceramide: a new lipid \u00e2\u20ac\u0153second messenger\u00e2\u20ac\u009d?","volume":"50","author":"Merrill","year":"1992","journal-title":"Nutr Rev"},{"key":"B16","doi-asserted-by":"crossref","first-page":"22156","DOI":"10.1016\/S0021-9258(20)80661-9","article-title":"A suppressor gene that enables Saccharomyces cerevisiae to grow without making sphingolipids encodes a protein that resembles an Escherichia coli fatty acyltransferase","volume":"268","author":"Nagiec","year":"1993","journal-title":"J Biol Chem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"25843","DOI":"10.1074\/jbc.R200009200","article-title":"De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway","volume":"277","author":"Merrill","year":"2002","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10298","DOI":"10.1021\/la8015589","article-title":"Molecular level investigation of organization in ternary lipid bilayer: a computational approach","volume":"24","author":"Mondal","year":"2008","journal-title":"Langmuir"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1021\/jp912175d","article-title":"Role of glycolipids in lipid rafts: a view through atomistic molecular dynamics simulations with galactosylceramide","volume":"114","author":"Hall","year":"2010","journal-title":"J Phys Chem B"},{"key":"B20","doi-asserted-by":"crossref","first-page":"18713","DOI":"10.1016\/S0021-9258(17)30565-3","article-title":"Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions","volume":"265","author":"Hakomori","year":"1990","journal-title":"J Biol Chem"},{"key":"B21","first-page":"F291","article-title":"Structure and function of renal glycosphingolipids","volume":"260","author":"Shayman","year":"1991","journal-title":"Am J Physiol"},{"key":"B22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/oxfordjournals.jbchem.a134667","article-title":"Gangliosides of various rat tissues: distribution of ganglio-N-tetraose-containing gangliosides and tissue-characteristic composition of gangliosides","volume":"95","author":"Iwamori","year":"1984","journal-title":"J Biochem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/abbi.2000.2206","article-title":"Gangliosides in rat kidney: composition, distribution, and developmental changes","volume":"386","author":"Saito","year":"2001","journal-title":"Arch Biochem Biophys"},{"key":"B24","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0022-5347(17)35956-6","article-title":"Aberrant expression of gangliosides in human renal cell carcinomas","volume":"150","author":"Hoon","year":"1993","journal-title":"J Urol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ki.1992.327","article-title":"A cell-type specific ganglioside of glomerular podocytes in rat kidney: an O-acetylated GD3","volume":"42","author":"Reivinen","year":"1992","journal-title":"Kidney Int"},{"key":"B26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ki.1994.14","article-title":"Nephron segment and cell-type specific expression of gangliosides in the developing and adult kidney","volume":"45","author":"Holthofer","year":"1994","journal-title":"Kidney Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency \u00e2\u20ac\u201c macrophage-targeted glucocerebrosidase for Gaucher\u00e2\u20ac\u2122s disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1073\/pnas.87.5.1913","article-title":"Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease","volume":"87","author":"Barton","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1182\/blood-2010-03-273151","article-title":"A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1","volume":"116","author":"Lukina","year":"2010","journal-title":"Blood"},{"key":"B31","first-page":"440","article-title":"Renal involvement in adult Gaucher\u00e2\u20ac\u2122s disease after splenectomy","volume":"103","author":"Chander","year":"1979","journal-title":"Arch Pathol Lab Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1093\/hmg\/ddq204","article-title":"Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting","volume":"19","author":"Vaccaro","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/hmg\/ddm040","article-title":"Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking","volume":"16","author":"Sun","year":"2007","journal-title":"Hum Mol Genet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0024-3205(68)90024-6","article-title":"Deficient hexozaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs","volume":"7","author":"Sandhoff","year":"1968","journal-title":"Life Sci"},{"key":"B35","first-page":"503","article-title":"Sandhoff disease","volume":"31","author":"Tatematsu","year":"1981","journal-title":"Acta Pathol Jpn"},{"key":"B36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism","volume":"11","author":"Sango","year":"1995","journal-title":"Nat Genet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1001\/archneur.63.3.453","article-title":"Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome","volume":"63","author":"Nance","year":"2006","journal-title":"Arch Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1515\/CCLM.2010.048","article-title":"Determination of globotriaosylceramide in plasma and urine by mass spectrometry","volume":"48","author":"Kr\u00c3\u00bcger","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1651-2227.2005.tb02112.x","article-title":"Is globotriaosylceramide a useful biomarker in Fabry disease?","volume":"94","author":"Young","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"B40","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1373\/clinchem.2012.192138","article-title":"Quantification of globotriaosylsphingosine in plasma and urine of fabry patients by stable isotope ultraperformance liquid chromatography-tandem mass spectrometry","volume":"59","author":"Gold","year":"2012","journal-title":"Clin Chem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.cca.2010.07.038","article-title":"How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?","volume":"411","author":"Auray-Blais","year":"2010","journal-title":"Clin Chim Acta"},{"key":"B42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00428-007-0468-6","article-title":"Cellular and tissue localization of globotriaosylceramide in Fabry disease","volume":"451","author":"Askari","year":"2007","journal-title":"Virchows Arch"},{"issue":"Suppl 2","key":"B43","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1097\/01.ASN.0000016684.07368.75","article-title":"Renal pathology in Fabry disease","volume":"13","author":"Alroy","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney Int"},{"key":"B45","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ki.2010.484","article-title":"Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease","volume":"79","author":"Najafian","year":"2011","journal-title":"Kidney Int"},{"key":"B46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.gene.2013.11.073","article-title":"Reduced glucosylceramide in the mouse model of Fabry disease: correction by successful enzyme replacement therapy","volume":"536","author":"Quinta","year":"2014","journal-title":"Gene"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e25065","DOI":"10.1371\/journal.pone.0025065","article-title":"Receptor-mediated endocytosis of alpha-galactosidase A in human podocytes in Fabry disease","volume":"6","author":"Prabakaran","year":"2011","journal-title":"PLoS One"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e63506","DOI":"10.1371\/journal.pone.0063506","article-title":"Dysregulated autophagy contributes to podocyte damage in Fabry\u00e2\u20ac\u2122s disease","volume":"8","author":"Liebau","year":"2013","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.284.5418.1372","article-title":"UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation","volume":"284","author":"Keppler","year":"1999","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1172\/JCI30954","article-title":"Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine","volume":"117","author":"Galeano","year":"2007","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e29873","DOI":"10.1371\/journal.pone.0029873","article-title":"Glycoprotein hyposialylation gives rise to a nephrotic-like syndrome that is prevented by sialic acid administration in GNE V572L point-mutant mice","volume":"7","author":"Ito","year":"2012","journal-title":"PLoS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3109\/00365517109080235","article-title":"Ceramides in a patient with lipogranulomatosis (Farber\u00e2\u20ac\u2122s disease) with chronic course","volume":"27","author":"Samuelsson","year":"1971","journal-title":"Scand J Clin Lab Invest"},{"key":"B53","first-page":"185","article-title":"Adult Niemann-Pick disease: a 26 years follow-up. Report of a case with isolated visceral involvement, excess of tissue sphingomyelin, and deficient sphingomyelinase activity (author\u00e2\u20ac\u2122s transl)","volume":"16","author":"Bri\u00c3\u00a8re","year":"1976","journal-title":"Nouv Rev Fr Hematol Blood Cells"},{"key":"B54","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0344-0338(97)80025-8","article-title":"Pathology of visceral organs and bone marrow in an acid sphingomyelinase deficient knock-out mouse line, mimicking human Niemann-Pick disease type A. A light and electron microscopic study","volume":"193","author":"Kuemmel","year":"1997","journal-title":"Pathol Res Pract"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1096\/fj.00-0014com","article-title":"Infusion of recombinant human acid sphingomyelinase into Niemann-pick disease mice leads to visceral, but not neurological, correction of the pathophysiology","volume":"14","author":"Miranda","year":"2000","journal-title":"FASEB J"},{"key":"B56","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/BF02409005","article-title":"Sphingolipid activator proteins in a human hereditary renal disease with deposition of disialogangliosides","volume":"28","author":"Haltia","year":"1996","journal-title":"Histochem J"},{"key":"B57","first-page":"1045","article-title":"The role of sulfatides in autoimmunity in children with various glomerular disease","volume":"33","author":"Tamaoki","year":"1991","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"B58","first-page":"155","article-title":"Role of tumour necrosis factor alpha and CD95 as markers of apoptosis in pathogenesis of pediatrics renal diseases","volume":"12","author":"Twfeek","year":"2005","journal-title":"Egypt J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1126\/science.277.5332.1652","article-title":"Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis","volume":"277","author":"De Maria","year":"1997","journal-title":"Science"},{"key":"B60","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1084\/jem.187.6.897","article-title":"Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells","volume":"187","author":"De Maria","year":"1998","journal-title":"J Exp Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1084\/jem.180.4.1547","article-title":"Apoptotic signaling through CD95 (Fas\/Apo-1) activates an acidic sphingomyelinase","volume":"180","author":"Cifone","year":"1994","journal-title":"J Exp Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s11064-006-9147-2","article-title":"Molecular mechanisms of GD3-induced apoptosis in U-1242 MG glioma cells","volume":"31","author":"Omran","year":"2006","journal-title":"Neurochem Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1074\/jbc.274.9.5267","article-title":"Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase","volume":"274","author":"Wiegmann","year":"1999","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/jat.1256","article-title":"Renal gangliosides are involved in lead intoxication","volume":"28","author":"Aguilar","year":"2008","journal-title":"J Appl Toxicol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s001250051447","article-title":"Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria","volume":"42","author":"Meyer","year":"1999","journal-title":"Diabetologia"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1046\/j.1523-1755.2001.0590062104.x","article-title":"Glomerular cell number in normal subjects and in type 1 diabetic patients","volume":"59","author":"Steffes","year":"2001","journal-title":"Kidney Int"},{"issue":"10","key":"B67","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/sj.ki.5002531","article-title":"Apoptosis in the kidneys of patients with type II diabetic nephropathy","volume":"72","author":"Verzola","year":"2007","journal-title":"Kidney Int"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.2337\/diabetes.51.10.3083","article-title":"Podocyte number in normotensive type 1 diabetic patients with albuminuria","volume":"51","author":"White","year":"2002","journal-title":"Diabetes"},{"key":"B69","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1172\/JCI119163","article-title":"Podocyte loss and progressive glomerular injury in type II diabetes","volume":"99","author":"Pagtalunan","year":"1997","journal-title":"J Clin Invest"},{"key":"B70","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/BF01469685","article-title":"Plasma glycosphingolipids in diabetics and normals","volume":"53","author":"Kremer","year":"1975","journal-title":"Klin Wochenschr"},{"key":"B71","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2337\/db08-1228","article-title":"Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance","volume":"58","author":"Haus","year":"2009","journal-title":"Diabetes"},{"key":"B72","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/jcp.22745","article-title":"Ceramide metabolism is affected by obesity and diabetes in human adipose tissue","volume":"227","author":"B\u00c5\u201aachnio-Zabielska","year":"2011","journal-title":"J Cell Physiol"},{"key":"B73","first-page":"CR35\u00e2\u20ac\u201c8","article-title":"Concentrations of sphingosine and sphinganine in plasma of patients with type 2 diabetes","volume":"11","author":"Gorska","year":"2005","journal-title":"Med Sci Monit"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.febslet.2004.12.094","article-title":"Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels","volume":"579","author":"Geoffroy","year":"2005","journal-title":"FEBS Lett"},{"key":"B75","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1172\/JCI116299","article-title":"A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus","volume":"91","author":"Zador","year":"1993","journal-title":"J Clin Invest"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/S0024-3205(03)00090-0","article-title":"Decreases of ganglioside GM3 in streptozotocin-induced diabetic glomeruli of rats","volume":"72","author":"Kwak","year":"2003","journal-title":"Life Sci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/ndt\/gfq633","article-title":"Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin","volume":"26","author":"Liu","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"B78","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1681\/ASN.2013111213","article-title":"SMPDL3b expression levels determine podocyte injury phenotypes in glomerular disease","volume":"25","author":"Yoo","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2369-13-70","article-title":"Changes in the gene expression programs of renal mesangial cells during diabetic nephropathy","volume":"13","author":"Brunskill","year":"2012","journal-title":"BMC Nephrol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-014-0933-x","article-title":"Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor","author":"Ishizawa","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.2337\/db06-0330","article-title":"Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk","volume":"55","author":"Samad","year":"2006","journal-title":"Diabetes"},{"key":"B82","first-page":"1009","article-title":"Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat","volume":"149","author":"Holthofer","year":"1996","journal-title":"Am J Pathol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ki.1979.49","article-title":"Glomerular epithelial alterations resulting from sialic acid surface coat removal","volume":"15","author":"Andrews","year":"1979","journal-title":"Kidney Int"},{"key":"B84","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.yexcr.2013.10.017","article-title":"Sialic acid attenuates puromycin aminonucleoside-induced desialylation and oxidative stress in human podocytes","volume":"320","author":"Pawluczyk","year":"2013","journal-title":"Exp Cell Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1523-1755.2000.00152.x","article-title":"HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy","volume":"58","author":"Barisoni","year":"2000","journal-title":"Kidney Int"},{"key":"B86","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1172\/JCI119525","article-title":"Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression","volume":"100","author":"Bruggeman","year":"1997","journal-title":"J Clin Invest"},{"key":"B87","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/ki.2009.366","article-title":"HIV-1 entry into human podocytes is mediated through lipid rafts","volume":"77","author":"Mikulak","year":"2010","journal-title":"Kidney Int"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1073\/pnas.89.5.1577","article-title":"Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes","volume":"89","author":"Kopp","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/01.ASN.0000019642.55998.69","article-title":"HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes","volume":"13","author":"Husain","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1046\/j.1523-1755.2000.00271.x","article-title":"Glomerulosclerosis and viral gene expression in HIV-transgenic mice: role of nef","volume":"58","author":"Kajiyama","year":"2000","journal-title":"Kidney Int"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1046\/j.1523-1755.2003.00283.x","article-title":"Critical role for Nef in HIV-1-induced podocyte dedifferentiation","volume":"64","author":"Sunamoto","year":"2003","journal-title":"Kidney Int"},{"key":"B92","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.virol.2005.10.010","article-title":"HIV-1 Nef mutations abrogating downregulation of CD4 affect other Nef functions and show reduced pathogenicity in transgenic mice","volume":"346","author":"Hanna","year":"2006","journal-title":"Virology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1046\/j.1523-1755.1999.00278.x","article-title":"Recruitment of renal tubular epithelial cells expressing verotoxin-1 (Stx1) receptors in HIV-1 transgenic mice with renal disease","volume":"55","author":"Liu","year":"1999","journal-title":"Kidney Int"},{"key":"B95","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1053\/j.ajkd.2004.07.008","article-title":"Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States","volume":"44","author":"Kitiyakara","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B96","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1399-3046.2004.00181.x","article-title":"Outcomes after renal transplantation for FSGS in children","volume":"8","author":"Baum","year":"2004","journal-title":"Pediatr Transplant"},{"key":"B97","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00467-004-1706-7","article-title":"Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience","volume":"20","author":"Hubsch","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF00858431","article-title":"Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts","volume":"4","author":"Senggutuvan","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1681\/ASN.2013040363","article-title":"Rituximab treatment prevents the early development of proteinuria following pig-to-baboon xeno-kidney transplantation","volume":"25","author":"Tasaki","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2008","journal-title":"Nat Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1681\/ASN.2012030302","article-title":"Circulating suPAR in two cohorts of primary FSGS","volume":"23","author":"Wei","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"B103","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.2337\/db13-0399","article-title":"Cyclodextrin protects podocytes in diabetic kidney disease","volume":"62","author":"Merscher-Gomez","year":"2013","journal-title":"Diabetes"},{"key":"B104","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.advenzreg.2009.01.011","article-title":"New aspects of sphingosine 1-phosphate signaling in mammalian cells","volume":"49","author":"Pyne","year":"2009","journal-title":"Adv Enzyme Regul"},{"key":"B105","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nri1650","article-title":"Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network","volume":"5","author":"Rosen","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.etp.2009.02.068","article-title":"Unbalanced expression of sphingosine 1-phosphate receptors in diabetic nephropathy","volume":"62","author":"Imasawa","year":"2010","journal-title":"Exp Toxicol Pathol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.bbalip.2013.07.011","article-title":"PPARgamma agonists upregulate sphingosine 1-phosphate (S1P) receptor 1 expression, which in turn reduces S1P-induced [Ca(2+)]i increases in renal mesangial cells","volume":"1831","author":"Koch","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/ki.2010.544","article-title":"Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes","volume":"79","author":"Awad","year":"2011","journal-title":"Kidney Int"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/labinvest.2010.102","article-title":"Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation","volume":"90","author":"Park","year":"2010","journal-title":"Lab Invest"},{"key":"B110","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000298339","article-title":"Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1-phosphate generation","volume":"31","author":"Kim","year":"2010","journal-title":"Am J Nephrol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"F1516","DOI":"10.1152\/ajprenal.00311.2005","article-title":"Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney","volume":"290","author":"Awad","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/ki.2011.281","article-title":"Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation","volume":"80","author":"Park","year":"2011","journal-title":"Kidney Int"},{"key":"B113","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1046\/j.1523-1755.1998.00772.x","article-title":"Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure","volume":"53","author":"Zager","year":"1998","journal-title":"Kidney Int"},{"key":"B114","first-page":"F723","article-title":"Renal cortical ceramide patterns during ischemic and toxic injury: assessments by HPLC-mass spectrometry","volume":"277","author":"Kalhorn","year":"1999","journal-title":"Am J Physiol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/ki.1997.304","article-title":"Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure","volume":"52","author":"Zager","year":"1997","journal-title":"Kidney Int"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/j.1523-1755.2004.00906.x","article-title":"Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis","volume":"66","author":"Peters","year":"2004","journal-title":"Kidney Int"},{"key":"B117","doi-asserted-by":"publisher","first-page":"F1761","DOI":"10.1152\/ajprenal.00253.2006","article-title":"S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis","volume":"292","author":"Martini","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/bcpt.12103","article-title":"Targeting the sphingosine kinase\/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases","volume":"114","author":"Schwalm","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"549S","DOI":"10.1016\/j.transproceed.2004.01.061","article-title":"FTY720 immunomodulation: optimism for improved transplant regimens","volume":"36","author":"Ferguson","year":"2004","journal-title":"Transplant Proc"},{"key":"B120","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/01.tp.0000232687.78242.cd","article-title":"Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation","volume":"82","author":"Fujishiro","year":"2006","journal-title":"Transplantation"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s10875-012-9710-3","article-title":"Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus","volume":"32","author":"Watson","year":"2012","journal-title":"J Clin Immunol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"e53521","DOI":"10.1371\/journal.pone.0053521","article-title":"Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis","volume":"8","author":"Snider","year":"2013","journal-title":"PLoS One"},{"key":"B123","doi-asserted-by":"publisher","first-page":"7962","DOI":"10.1073\/pnas.96.14.7962","article-title":"Nephrin is specifically located at the slit diaphragm of glomerular podocytes","volume":"96","author":"Ruotsalainen","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B124","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1681\/ASN.V10112440","article-title":"Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm","volume":"10","author":"Tryggvason","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B125","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","article-title":"A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression","volume":"13","author":"Saleem","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s001090050206","article-title":"Regulation of podocyte structure during the development of nephrotic syndrome","volume":"76","author":"Smoyer","year":"1998","journal-title":"J Mol Med (Berl)"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1172\/JCI200114629","article-title":"Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis","volume":"108","author":"Kerjaschki","year":"2001","journal-title":"J Clin Invest"},{"key":"B128","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10157-003-0259-6","article-title":"The role of podocytes in glomerular pathobiology","volume":"7","author":"Asanuma","year":"2003","journal-title":"Clin Exp Nephrol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1177\/002215540305101203","article-title":"Actin filament organization of foot processes in rat podocytes","volume":"51","author":"Ichimura","year":"2003","journal-title":"J Histochem Cytochem"},{"key":"B130","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00441-007-0440-4","article-title":"Actin filament organization of foot processes in vertebrate glomerular podocytes","volume":"329","author":"Ichimura","year":"2007","journal-title":"Cell Tissue Res"},{"key":"B131","doi-asserted-by":"publisher","first-page":"F585","DOI":"10.1152\/ajprenal.00290.2001","article-title":"Podocyte slit-diaphragm protein nephrin is linked to the actin cytoskeleton","volume":"282","author":"Yuan","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1093\/hmg\/ddg360","article-title":"Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains","volume":"12","author":"Huber","year":"2003","journal-title":"Hum Mol Genet"},{"key":"B133","doi-asserted-by":"publisher","first-page":"41543","DOI":"10.1074\/jbc.C100452200","article-title":"Interaction with podocin facilitates nephrin signaling","volume":"276","author":"Huber","year":"2001","journal-title":"J Biol Chem"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1096\/fj.02-0121fje","article-title":"Isolation and functional characterization of the actin binding region in the tight junction protein ZO-1","volume":"16","author":"Fanning","year":"2002","journal-title":"FASEB J"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/S0002-9440(10)61782-8","article-title":"Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm","volume":"159","author":"Simons","year":"2001","journal-title":"Am J Pathol"},{"issue":"Pt 2","key":"B136","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj3240481","article-title":"Sphingosine 1-phosphate stimulates rho-mediated tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 fibroblasts","volume":"324","author":"Wang","year":"1997","journal-title":"Biochem J"},{"key":"B137","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0006-291X(02)02483-X","article-title":"Identification of the LIM kinase-1 as a ceramide-regulated gene in renal mesangial cells","volume":"298","author":"Shabahang","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"B138","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1242\/jcs.01246","article-title":"Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells","volume":"117","author":"Takenouchi","year":"2004","journal-title":"J Cell Sci"},{"key":"B139","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2012.08.037","article-title":"Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function","volume":"151","author":"Jin","year":"2012","journal-title":"Cell"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T23:50:16Z","timestamp":1649807416000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2014.00127\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,30]]},"references-count":139,"URL":"https:\/\/doi.org\/10.3389\/fendo.2014.00127","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,30]]}}}